MX
MaxCyte, Inc.
MXCT · NASDAQ
$1.16 -3.33% (-$0.04)
1M -16.55%
Market Cap $127.5M
P/E Ratio -
Div. Yield -
ROE 21.01%
Piotroski F-Score Weak
2/9Valuation
72 /100
Cheap P/S 4.11x
P/B 0.80x
P/E N/A
Growth
0 /100
Declining Rev. growth 9.30%
Book val. growth 12.27%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 79.43%
Net margin 114.77%
Op. margin 111.63%
Quality
2 /100
Poor ROIC 19.66%
ROE 21.01%
ROA 19.30%
Debt
100 /100
Low Debt/Equity 0.11x
Current ratio 12.26x
Int. coverage N/A
Stability
49 /100
Moderate Beta 1.53x
Rev. volatility 4.57%
EPS volatility 50.93%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na MXCT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Maher Masoud
Employees
91
Headquarters
Rockville
Nadcházející události
11 LIS
Earnings
Upcoming earnings report